SciELO - Scientific Electronic Library Online

 
vol.94 suppl.1Síndrome poscovid en pediatríaProblemas de salud en niños y adolescentes durante la pandemia ocasionada por la COVID-19 índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Cubana de Pediatría

versión impresa ISSN 0034-7531versión On-line ISSN 1561-3119

Resumen

TAMAYO MARINO, Katiuska; VELAZQUEZ AVILA, Yordania  y  RODRIGUEZ VALENCIANO, Carmen Rosa. Risks for the child diagnosed with mastocytosis in the face of COVID-19 infection. Rev Cubana Pediatr [online]. 2022, vol.94, suppl.1, e2499.  Epub 20-Mayo-2022. ISSN 0034-7531.

Introduction:

Mastocytosis is characterized by the accumulation of mast cells in various organs, especially in the skin, with alteration of the immune response. In Las Tunas province, it represents 5.17% of genodermatoses. COVID-19, caused by the SARS-CoV-2 virus, shows high lethality in the world and also affects the pediatric population. Cases that evolve into the complicated form of the disease are those with associated comorbidities and immune system disorders.

Objective:

To compile information on the main risks for children diagnosed with mastocytosis and COVID-19 infection.

Methods:

The literature available in Scopus, SciELO, PubMed Central, MedlinePlus, Clinicalkey, LILACS, Orphanet, OMIM, WHO, PAHO, and MINSAP was reviewed. The descriptors used were: medical genetics, genetic dermatological diseases, mastocytosis, human coronavirus, SARS-CoV-2, COVID-19. During the review process, 5 books and 21 articles published in the last 5 years were consulted.

Analysis and synthesis of information:

Based on the etiopathogenesis and clinical manifestations of mastocytosis and COVID-19, the main risks for the child diagnosed with mastocytosis are shown, such as urticarial manifestations, anaphylaxis and mast cell activation syndrome that can lead the child to develop severe COVID-19. Elements to take into account to treat these patients are included.

Conclusions:

In infants diagnosed with mastocytosis there are risks of developing complications due to COVID-19 infection, and recognizing them, allows improving their care.

Palabras clave : genodermatosis; mastocytosis; coronavirus; SARS-CoV-2; COVID-19.

        · resumen en Español     · texto en Español     · Español ( pdf )